Get started
Author

Shin‐ichi Fuchida

Observed names: S Fuchida, S.‐I. FUCHIDA, SHIN-ICHI FUCHIDA, Shin-Ichi Fuchida, Shin-ichi Fuchida, Shinichi Fuchida, Shin‐Ichi Fuchida
Observed institutions: Kansai Medical University, Himeji Dokkyo University, Kyoto University, Kyoto Medical Center, Kyoto Prefectural University of Medicine, Japan Community Healthcare Organization, Aichi Cancer Center, National Hospital Organization, Osaka Red Cross Hospital, Okayama Medical Center, Nagoya Medical Center, HLA Laboratory, Kyoto Kuramaguchi Medical Center, Aichi Cancer Center Hospital
ORCID: 0000-0002-4147-9113
Observed ORCID: 0000-0002-4147-9113
OpenAlex ID: A5000213564
Non–T-cell–depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism
2003 · Chihiro Shimazaki, Naoya Ochiai, et al. · Blood · 79
Effect of farnesyl transferase inhibitor R115777 on the growth of fresh and cloned myeloma cells in vitro
2003 · Naoya Ochiai, Ryo Uchida, et al. · Blood · 50
t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs
2015 · T Narita, A Inagaki, et al. · Blood Cancer Journal · 45
PDF
Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma
2018 · Kazuna Tanba, Yoshiaki Chinen, et al. · Blood Cancer Journal · 36
PDF
Disseminated Infection Due to Scedosporium apiospermum in a Patient with Acute Myelogenous Leukemia
2002 · Naoya Ochiai, Chihiro Shimazaki, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 33
Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia
2002 · N Ochiai, C Shimazaki, et al. · Bone Marrow Transplantation · 29
Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL
2022 · Kazuaki Kameda, Shinichi Kako, et al. · Leukemia · 26
CD5+ Epstein-Barr virus-positive intravascular large B-cell lymphoma in the uterus co-existing with huge myoma
2005 · Noriko Yamada, Ryo Uchida, et al. · American Journal of Hematology · 26
PDF
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine
2021 · Yutaka Shimazu, Shohei Mizuno, et al. · Cancer Science · 21
PDF
Plasmacytoma of the Urinary Bladder in a Renal Transplant Recipient
2005 · Ryoichi Takahashi, Sonoko Nakano, et al. · International Journal of Hematology · 20
Non‐T‐cell‐depleted HLA‐haploidentical stem cell transplantation after reduced‐intensity conditioning in advanced haematological malignancies based on feto‐maternal microchimerism
2004 · Chihiro Shimazaki, Shin‐ichi Fuchida, et al. · British Journal of Haematology · 18
PDF
Limited value of the international staging system for predicting long-term outcome of transplant-ineligible, newly diagnosed, symptomatic multiple myeloma in the era of novel agents
2014 · Kansai Myeloma Forum Investigators, Junya Kuroda, et al. · International Journal of Hematology · 17
Pharmacokinetic Interaction Between Tacrolimus and Fentanyl in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
2017 · Fumiaki Kitazawa, Shin-ichi Fuchida, et al. · Annals of Transplantation · 16
Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis
2022 · Yoshiyuki Onda, Junya Kanda, et al. · Therapeutic Advances in Hematology · 15
PDF
Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum
2018 · Kansai Myeloma Forum Investigators, Yayoi Matsumura-Kimoto, et al. · International Journal of Hematology · 15
Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma
2012 · Miki Kiyota, Tsutomu Kobayashi, et al. · International Journal of Hematology · 15
Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis
2021 · Teruhito Takakuwa, Ryosuke Yamamura, et al. · European Journal Of Haematology · 13
Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry
2020 · Aya Nakaya, Takae Kohara, et al. · International Journal of Hematology · 13
Combination Therapy with Thalidomide, Incadronate, and Dexamethasone for Relapsed or Refractory Multiple Myeloma
2005 · Naoya Ochiai, Noriko Yamada, et al. · International Journal of Hematology · 13
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021)
2024 · Hirohiko Shibayama, Mitsuhiro Itagaki, et al. · International Journal of Hematology · 12
PDF
The effects of thalidomide on chemotactic migration of multiple myeloma cell lines
2007 · S.‐I. FUCHIDA, C. SHIMAZAKI, et al. · International Journal of Laboratory Hematology · 12
Prognostic value of minimal residual disease detected by EuroFlow next-generation flow cytometry and next-generation sequencing in patients with multiple myeloma achieving complete response and receiving lenalidomide maintenance after autotransplant: a prospective comparison study
2025 · Takeshi Yoroidaka, Hiroyuki Takamatsu, et al. · Haematologica · 11
PDF
Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myeloma
2014 · KMF investigators, Tsutomu Kobayashi, et al. · International Journal of Hematology · 10
CD5‐negative chronic lymphocytic leukemia with indolent clinical course and autoimmune thrombocytopenia, successfully treated with rituximab
2004 · Masashi Okamoto, Sonoko Nakano, et al. · American Journal of Hematology · 10
PDF
Prognostic impact of resistance to bortezomib and/or lenalidomide in carfilzomib‐based therapies for relapsed/refractory multiple myeloma: The Kyoto Clinical Hematology Study Group, multicenter, pilot, prospective, observational study in Asian patients
2021 · Yuka Kawaji‐Kanayama, Tsutomu Kobayashi, et al. · Cancer Reports · 9
Works count: 118
Citation count: 767
H-index: 15
I10-index: 24
Year
Topic
Type